Table 4.

Number (%) of patients with the most common adverse events during the treatment period (whether or not drug related, >3%)

Adverse event	Tegaserod (n (%))	Placebo (n (%))
Headache	31 (12.0)	29 (11.1)
Diarrhoea	26 (10.0)	8 (3.1)
Abdominal pain (not specified)	15 (5.8)	8 (3.1)
Upper respiratory tract infection	15 (5.8)	20 (7.7)
Nausea	11 (4.2)	9 (3.4)
Dizziness	10 (3.9)	9 (3.4)
Pyrexia	9 (3.5)	4 (1.5)
Nasopharyngitis	7 (2.7)	8 (3.1)
Abdominal distension	6 (2.3)	8 (3.1)
Abdominal pain, upper	6 (2.3)	11 (4.2)